
Opinion|Videos|September 13, 2024
Biosimilar Copay Programs
Author(s)Sophia Humphreys, PharmD, MHA
Dr Humphreys discusses biosimilar copay programs.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How do copay programs impact the adoption of biosimilars for patients, and what role can the pharmacy staff play in educating patients about these programs?
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
CKD Outcome Set Elevates Patient-Reported Measures
2
The PBM Reform Clock Is Running to 2028—Here's What Independent Pharmacies Should Do
3
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
4
Preoperative GLP-1 Use Doesn't Change Bariatric Weight Loss Outcomes
5



































































































